Spotlight -

B + L Dry Eye Series|

Transforming Glaucoma Management|

Zeiss Clinical Cases

Viewing

|Articles|July 1, 2009

Regimen change cuts eye drops use in half

How hyaluronic acid-based eye drops can help repair nerve damage.

Newsletter

Don’t miss out—get OT Europe updates delivered straight to your inbox.

Related Content

(Image credit: David Pinero) Visual training may ease neuroadaptation to presbyopia-correcting IOLs

Visual training may ease neuroadaptation to presbyopia-correcting IOLs

ByDavid P. Piñero, PhD

September 5th 2026

(Ophthalmology Times Europe) Single-use instruments in cataract surgery: Beyond the backup role

Single-use instruments in cataract surgery: Beyond the backup role

ByBen LaHood, PhD, PGDipOphth, MBChB, FRANZCO

August 7th 2026

(Ophthalmology Times Europe) Synthetic corneal implant shows promise in eyes with chronic corneal oedema

Synthetic corneal implant shows promise in eyes with chronic corneal oedema

ByOphthalmology Times Europe Staff

July 4th 2026

Mikhail Boukhny and Andy Chang | Ophthalmology Times Europe

Hands-on training, real surgeon input: inside BVI's new Experience Hub

ByMikhail Boukhny,Andy Chang,Lucia Gambuzza

July 3rd 2026

How the ocular microbiome may shape outcomes in keratoplasty

ByOphthalmology Times Europe Staff

July 2nd 2026

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Treatment Optimization in the Evolving Anti-VEGF Era

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery